RBC Europe’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$25K Hold
580
﹤0.01% 400
2022
Q1
$31K Buy
580
+110
+23% +$6.4K ﹤0.01% 406
2021
Q4
$34K Sell
470
-93,610
-100% -$5.87M ﹤0.01% 397
2021
Q3
$5.35M Buy
94,080
+190
+0.2% +$11.6K 0.22% 62
2021
Q2
$6.11M Buy
93,890
+480
+0.5% +$30.3K 0.28% 56
2021
Q1
$5.56M Buy
93,410
+13,770
+17% +$750K 0.3% 54
2020
Q4
$3.76M Sell
79,640
-770
-1% -$32.4K 0.22% 68
2020
Q3
$2.67M Buy
80,410
+40,610
+102% +$1.4M 0.18% 79
2020
Q2
$1.29M Buy
+39,800
New +$1.09M 0.1% 104
2018
Q3
Sell
-60
Closed -$1.04K 1158
2018
Q2
$1.04K Sell
60
-1,160
-95% -$22.3K ﹤0.01% 1078
2018
Q1
$24.8K Buy
1,220
+90
+8% +$1.78K ﹤0.01% 627
2017
Q4
$20.8K Buy
+1,130
New +$22.2K ﹤0.01% 672

Other funds holding LRCX

RBC Europe's LRCX Position: Q2 2022 in Review

RBC Europe held its Lam Research (LRCX) position steady in Q2 2022 at 580 shares worth $25K. The position accounts for ﹤0.01% of the portfolio, ranked #400.

RBC Europe first reported a position in LRCX in Q4 2017 and has held it in 12 quarters since. The position peaked at $6.11M in Q2 2021. 1,307 funds tracked by Wall St. Rank hold LRCX as of Q2 2022.

  • RBC Europe held 580 shares of Lam Research worth $25K as of Q2 2022.
  • RBC Europe left its Lam Research share count unchanged in Q2 2022.
  • Lam Research made up ﹤0.01% of RBC Europe's portfolio in Q2 2022, its #400 holding.
  • RBC Europe first reported a position in Lam Research in Q4 2017 and has held it in 12 quarters since.
  • RBC Europe's Lam Research position peaked at $6.11M in Q2 2021.
  • 1,307 funds tracked by Wall St. Rank held Lam Research as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.